Trajectory, risk factors, and impact of abdominal pain during the first year after pediatric IBD diagnosis: Results from the ImproveCareNow Network

Murphy L, Gashi K, Kawamura J, Zhou C, Lynch D, Suskind D, Palermo T. Trajectory, risk factors, and impact of abdominal pain during the first year after pediatric IBD diagnosis: Results from the ImproveCareNow Network. J Pediatr Gastroenterol Nutr 69 2019;(S1): S95-96

Reduction in corticosteroid usage among pediatric patients with inflammatory bowel disease in a large learning health system

Kandavel P, Adler J, Meister S. Reduction in corticosteroid usage among pediatric patients with inflammatory bowel disease in a large learning health system. J Pediatr Gastroenterol Nutr 69 2019;(S1): S232-233

Insurance status but not race determines sustained remission in pediatric IBD

Doan S, Jofriet A, Scott O, Riswan A, Venkateswaran S, Somineni H, Niklinska-Schirtz B, Talmadge C, Fritzen C, Dinser M, Dykes D, Gold B, Sauer C, Kugathasan S, Schoen B. Insurance status but not race determines sustained remission in pediatric IBD. J Pediatr Gastroenterol Nutr 69 2019;(S1): S80-81

Anemia prevalence in pediatrics IBD: Still persisted after 1 year

Malik P, Kim M, Puopolo G, Thompson J, Tomer G. Anemia prevalence in pediatrics IBD: Still persisted after 1 year. J Pediatr Gastroenterol Nutr 69 2019;(S1): S244-245

Hospitalizations in children with inflammatory bowel disease

Alper A, Algara M, Phatak U, Pashankar D. Hospitalizations in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 69 2019;(S1): S64-65

Treatment of pediatric Crohn's disease patients with early perianal complications

Adler J, Gadepalli S, Zacur G, Jarboe M, Dombkowski K. Treatment of pediatric Crohn's disease patients with early perianal complications. Inflamm Bowel Dis 24 2018;(S1): S79

"A Guide to Gutsy Living": Patient Driven Development of a Pediatric Ostomy Toolkit

David J, Jofriet A, Seid M, Margolis PA. "A Guide to Gutsy Living": Patient Driven Development of a Pediatric Ostomy Toolkit. Pediatrics 2018;141(5): e20172789

Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure

Gupta N, King E, Liu C, Sylvester F, Lee D, Boyle B, Trauernicht A, Chen S, Pratt J, Colletti R. Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure. Gastroenterology 154 2018;(6): S670

Factors associated with discontinuation of initial and subsequent tumour necrosis factor inhibitors in a large paediatric inflammatory bowel disease observational cohort

Kaplan J, Liu C, King E, Bass J, Patel A, Tomer G, Tung J, Pratt J, Chen S, Lissoos T, Colletti R. Factors associated with discontinuation of initial and subsequent tumour necrosis factor inhibitors in a large paediatric inflammatory bowel disease observational cohort. Gastroenterology 154 2018;(6): S669-670

Evaluation of adalimumab effectiveness in pediatric patients with ulcerative colitis in clinical practice

Steiner S, Liu C, King E, Israel E, Pasternak B, Schaefer M, Chen S, Pratt J, Lazar A, Bereswill M, Robinson A, Colletti R, ImproveCareNow Network. Evaluation of adalimumab effectiveness in pediatric patients with ulcerative colitis in clinical practice. Gastroenterology 154 2018;(6): S668-669

Patterns of use and durability of initial and sequential biological agents in a large paediatric inflammatory bowel disease observational cohort

Kaplan J, Liu C, King E, Bass J, Patel A, Tomer G, Tung J, Pratt J, Chen S, Lissoos T, Colletti R. Patterns of use and durability of initial and sequential biological agents in a large paediatric inflammatory bowel disease observational cohort. Gastroenterology 154 2018;(6): S669

Uveitis in a multicenter pediatric inflammatory bowel disease population: results from the Improvecarenow Network

Schaefer M, Nelson A, Sanchez R. Uveitis in a multicenter pediatric inflammatory bowel disease population: results from the Improvecarenow Network. Gastroenterology 154 2018;(6): S669

Evaluation of adalimumab effectiveness in paediatric patients with Ulcerative Colitis in clinical practice

Steiner S, Liu C, King E, Israel E, Pasternak B, Schaefer M, Chen S, Pratt J, Lazar A, Bereswill M, Robinson A, Colletti R, ImproveCareNow Network. Evaluation of adalimumab effectiveness in paediatric patients with Ulcerative Colitis in clinical practice. J Pediatr Gastroenterol Nutr 66 2018;(2): S41

Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure

Gupta N, King E, Liu C, Sylvester F, Lee D, Boyle B, Trauernicht A, Chen S, Pratt J, Colletti R. Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure. J Pediatr Gastroenterol Nutr 66 2018;(2): S563

Patterns of use and durability of initial and sequential biological agents in a large paediatric inflammatory bowel disease observational cohort

Kaplan J, Liu C, King E, Bass J, Patel A, Tomer G, Tung J, Pratt J, Chen S, Lissoos T, Colletti R. Patterns of use and durability of initial and sequential biological agents in a large paediatric inflammatory bowel disease observational cohort. J Pediatr Gastroenterol Nutr 66 2018;(2): S84

Factors associated with discontinuation of initial and subsequent tumour necrosis factor inhibitors in a large paediatric inflammatory bowel disease observational cohort

Kaplan J, Liu C, King E, Bass J, Patel A, Tomer G, Tung J, Pratt J, Chen S, Lissoos T, Colletti R. Factors associated with discontinuation of initial and subsequent tumour necrosis factor inhibitors in a large paediatric inflammatory bowel disease observational cohort. J Pediatr Gastroenterol Nutr 66 2018;(2): S96

Looking the truth in the eye-benchmarking cares and outcomes against the world's largest paediatric IBD registry

Hensel K, Cunion D, Gasparetto M, Brennan M, Folan A, Lee C, Torrente F, Zilbauer M, Heuschkel R. Looking the truth in the eye-benchmarking cares and outcomes against the world's largest paediatric IBD registry. J Pediatr Gastroenterol Nutr 66 2018;(2): S59

Use of cannabis and opiates by adolescents and young adults with inflammatory bowel disease

Hoffenberg E, Murphy B, Mikulich-Gilbertson S, McWilliams S, Hoffenberg A, Hopfer C. Use of cannabis and opiates by adolescents and young adults with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 67 2018;(S1): S62-63

Outcomes in pediatric IBD patients not receiving immunological therapies

Benkov KJ, Serphos D. Outcomes in pediatric IBD patients not receiving immunological therapies. J Pediatr Gastroenterol Nutr 67 2018;(S1): S191-192

Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure

Gupta N, King E, Liu C, Sylvester F, Lee D, Boyle B, Trauernicht A, Chen S, Pratt J, Colletti R. Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure. J Pediatr Gastroenterol Nutr 67 2018;(S1): S264-265

Implementing transition of care and transfer of care systems in pediatric IBD

Schaefer M, Tung J, Maddux M, Kim S (2017). Implementing transition of care and transfer of care systems in pediatric IBD. Inflamm Bowel Dis 2017;S73

Evaluation of adalimumab effectiveness in anti-tumor necrosis factor-naïve pediatric patients with Crohn's disease in clinical practice

Steiner S, King E, Park KT, Pashankar D, Shashidhar H, Sudel B, Eichner S, Chen S, Pratt J, Colletti R . Evaluation of adalimumab effectiveness in anti-tumor necrosis factor-naïve pediatric patients with Crohn's disease in clinical practice. Gastroenterol 2017;64:S70

Outcomes from patient pre-visit planning (PVP) in Pediatric Inflammatory Bowel Disease (PIBD) using the ImproveCareNow (ICN) tool

Chadokufa S, Wearon R. Outcomes from patient pre-visit planning (PVP) in Pediatric Inflammatory Bowel Disease (PIBD) using the ImproveCareNow (ICN) tool. J Pediatr Gastroenterol Nutr 2017;65(S1): S6

Evaluation of adalimumab effectiveness in anti-tumor necrosis factor-naïve pediatric patients with Crohn's disease in clinical practice

Steiner S, King E, Park KT, Pashankar D, Shashidhar H, Sudel B, Eichner S, Chen S, Pratt J, Colletti R. Evaluation of adalimumab effectiveness in anti-tumor necrosis factor-naïve pediatric patients with Crohn's disease in clinical practice. J Pediatr Gastroenterol Nutr 2017;65(S1):S50

Successful use of the ImproveCareNow (ICN) quality improvement tool: Our 7-year outcomes and achievements

Chadokufa S, Acton N, Sider S, Sheppard R, Wearon R, Shah N, Knaflez D, Kiparissi F. Successful use of the ImproveCareNow (ICN) quality improvement tool: Our 7-year outcomes and achievements. J Pediatr Gastroenterol Nutr 2017;65(S1): S196-203

Racial differences in initial presentation, early treatment, and 1-year outcomes of pediatric Crohn's disease: results from the ImproveCareNow network

Dotson JL, Cho M, Bricker J, Kappelman M, Chisolm D, Tomer G, Crandall W. Racial differences in initial presentation, early treatment, and 1-year outcomes of pediatric Crohn's disease: results from the ImproveCareNow network. Inflamm Bowel Dis 2016;22:doi: 10.1097/01

Feasibility of a mobile personalized learning system for assessing daily IBD symptoms and quality of life

Adler J, Saeed S, Thakkar S, Eslick I, Margolis P, Provost L, Kaplan H. Feasibility of a mobile personalized learning system for assessing daily IBD symptoms and quality of life. Inflamm Bowel Dis 2016;22:doi: 10.1097/01

The use of concomitant immunomodulators with adalimumab therapy in pediatric Crohn's disease

Benkov JK, Russell GH, Samson C, Steiner S, King E, Pratt J, Eichner S, Colletti RB. The use of concomitant immunomodulators with adalimumab therapy in pediatric Crohn's disease. Gastroenterol 2016;150(4):S588

The use of concomitant immunomodulators with adalimumab therapy in pediatric Crohn's disease

Benkov JK, Russell GH, Samson C, Steiner S, King E, Pratt J, Eichner S, Colletti RB. The use of concomitant immunomodulators with adalimumab therapy in pediatric Crohn's disease. J Pediatr Gastro Nutr 2016;62:77

Prevention of perianal disease among pediatric patients with Crohn's disease in a pediatric inflammatory bowel disease quality improvement collaborative

Adler J, Dong S, Dombkowski K. Prevention of perianal disease among pediatric patients with Crohn's disease in a pediatric inflammatory bowel disease quality improvement collaborative. J of Pediatr Gastro 2016;63:S364

Efficacy and safety of co-therapy of biologics and methotrexate in a pediatric inflammatory bowel disease (pIBD) cohort: a single centre experience

Lozinsky A, Kiparissi F, Huggett B, Chadokufa S, Sider S, Acton N, Baycheva M, Shah N. Efficacy and safety of co-therapy of biologics and methotrexate in a pediatric inflammatory bowel disease (pIBD) cohort: a single centre experience. J of Pediatr Gastro 2016;63(S2):S210-211

Identifying fistulizing Crohn's disease in a national pediatric inflammatory bowel disease quality improvement collaborative registry

Adler J, Dong S, Dombkowski K. Identifying fistulizing Crohn's disease in a national pediatric inflammatory bowel disease quality improvement collaborative registry. Gastroenterol 2015;148:S379

Racial differences in initial presentation and early treatment of pediatric Crohn's disease - preliminary results from the ImproveCareNow Network

Dotson J, Cho M, Bricker J, Kappelman M, Chisolm D, Tomer G, Crandall W. Racial differences in initial presentation and early treatment of pediatric Crohn's disease - preliminary results from the ImproveCareNow Network. Gastroenterol 2015;148:S71

Extent of disease in ulcerative colitis in a pediatric inflammatory bowel disease learning health network

Adler J, Grossman A, Israel EJ, Kim S, Saeed SA, Pratt JM, Collins J, Colletti RB, ImproveCareNow Network. Extent of disease in ulcerative colitis in a pediatric inflammatory bowel disease learning health network. J Pediatr Gastro Nutr 2015;61:S87

Real-world clinical and comparative effectiveness of infliximab in pediatric Crohn’s disease

Kappelman MD, Bailey LC, Crandall WV, Zhang P, King E, Joffe M, Colletti RB, Forrest, CB and the ImproveCareNow Network. Kappelman MD, Bailey LC, Crandall WV, Zhang P, King E, Joffe M, Colletti RB, Forrest, CB and the ImproveCareNow Network. Real-world clinical and comparative effectiveness of infliximab in pediatric Crohn’s disease. Gastroenterol 2013;144:S146

Use of the emergency department in pediatric inflammatory bowel disease

Hoffenberg EJ, Fridge J, Leibowitz I, Tsou M, Dykes D, Kappelman M, Colletti R. Use of the emergency department in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2013;57 (suppl 1):e63

Feasibility and validity of the pediatric ulcerative colitis activity index in real-world clinical practice

Dotson JL, Crandall WV, Zhang P, Forrest CB, Bailey LC, Colletti RB, Kappelman MD.  Feasibility and validity of the pediatric ulcerative colitis activity index in real-world clinical practice.  Inflamm Bowel Dis 2013

Is there seasonal variation of disease activity in pediatric-onset inflammatory bowel disease?

Burkam J, Kappelman M, King E, Pratt J, Colletti R, Bistrick S, Crandall W.  Is there seasonal variation of disease activity in pediatric-onset inflammatory bowel disease? Gastroenterol 2012;142:S209

Are there gender differences in the clinical outcomes of pediatric inflammatory bowel disease?

Lee G, Kappelman MD, Boyle B, Colletti R, King E, Pratt J, Crandall W.  Are there gender differences in the clinical outcomes of pediatric inflammatory bowel disease? Gastroenterol 2011;140:S196

Increased remission in a quality improvement collaborative for pediatric Crohn disease

Crandall W, Kappelman M, Colletti RB, Denson L, Duffy L, Grunow J, Kim S, Leibowitz I, Patel A, Schoen B, Tomer G, Milov D, Cohen S, Margolis P, and the ImproveCareNow Collaborative (formerly PIBDNet).  Increased remission in a quality improvement collaborative for pediatric Crohn disease.  Gastroenterol 2010;138:S29

Increased remission in a quality improvement collaborative for pediatric Crohn disease

Crandall W, Kappelman M, Colletti RB, Denson L, Duffy L, Grunow J, Kim S, Leibowitz I, Patel A, Schoen B, Tomer G, Milov D, Cohen S, Margolis P, and the ImproveCareNow Collaborative (formerly PIBDNet). Increased remission in a quality improvement collaborative for pediatric Crohn disease.  J Pediatr Gastroenterol Nutr 2009;48:e

A rapid pediatric Crohn's disease activity index for quality improvement and observational research

Kappelman, M, Goudie, A. Crandall, W, Larry, E, Fairbrother, G, Margolis, P, Leibowitz, I, Duffy, L, Milov, D, Kim, S, Schoen, B, Cohen, S, Patel, A, Grunow, J, Colletti, R, and the ImproveCareNow Collaborative (formerly PIBDNet). A rapid pediatric Crohn's disease activity index for quality improvement and observational research.  J Pediatr Gastroenterol Nutr 2009;48:e

Increased remission in a quality improvement collaborative for pediatric Crohn disease

Crandall W, Kappelman M, Colletti RB, Denson L, Duffy L, Grunow J, Kim S, Leibowitz I, Patel A, Schoen B, Tomer G, Milov D, Cohen S, Margolis P, and the ImproveCareNow Collaborative (formerly PIBDNet). Increased remission in a quality improvement collaborative for pediatric Crohn disease.  Inflamm Bowel Dis 2009;15:s3

A rapid pediatric Crohn's disease activity index for quality improvement and observational research

Kappelman, M, Goudie, A. Crandall, W, Larry, E, Fairbrother, G, Margolis, P, Leibowitz, I, Duffy, L, Milov, D, Kim, S, Schoen, B, Cohen, S, Patel, A, Grunow, J, Colletti, R, and the ImproveCareNow Collaborative (formerly PIBDNet).  A rapid pediatric Crohn's disease activity index for quality improvement and observational research.  Inflamm Bowel Dis 2009;15:s18

Accelerating improvement in the management of pediatric inflammatory bowel disease

Kappelman MD, Cohen SA, Crandall W, Duffy LF, Gold BD, Grunow J, Kim SC, Leibowitz I, Margolis P, Mehta DI, Milov DE, Moyer MS, Myers SK, Patel AS, Schoen BT, Sudel B, Colletti RB. Accelerating improvement in the management of pediatric inflammatory bowel disease.  Gastroenterol 2008;134(S1):A473

Growth failure in a pediatric inflammatory bowel disease registry (PIBDNet) with specific association to disease phenotype

Patel AS, Kim S, Kappelman M, Colletti R, Cohen S, Grunow J, Crandall W, Duffy L, Gold B, Leibowitz I, Margolis P, Mehta D, Milov D, Moyer S, Myers S, Schoen B, Sudel B, Bornstein J.  Growth failure in a pediatric inflammatory bowel disease registry (PIBDNet) with specific association to disease phenotype.  J Pediatr Gastroenterol Nutr 2008;47:e

The quality of care in pediatric inflammatory bowel disease: does the chronic care model work?

Kappelman M, Margolis P, Moyer M, Cohen S, Gold B, Crandall W, Patel A, Mehta D, Milov D, Grunow J, Leibowitz I, Colletti R.  The quality of care in pediatric inflammatory bowel disease: does the chronic care model work?  J Pediatr Gastroenterol Nutr 2007;45:e5

Variation in initial 6-mercaptopurine dosage in pediatric Crohn's disease

Colletti RB, Baldassano RN, Milov DE, Margolis PA, PIBDNet –the Pediatric IBD Network for Research and Improvement. Variation in initial 6-mercaptopurine dosage in pediatric Crohn's disease.  Gastroenterol 2006;130:A652

Predictors of outcome of treatment of pediatric Crohn’s disease with 6-mercaptopurine or azathioprine

Colletti RB, Baldassano RN, Milov DE, for PIBDNet—the Pediatric IBD Network for Research and Improvement. Predictors of outcome of treatment of pediatric Crohn’s disease with 6-mercaptopurine or azathioprine.  J Pediatr Gastroenterol 2006;43(supp2):S40

Initial dosage of 6-mercaptopurine in pediatric Crohn’s disease: a study of variation in care

Colletti RB, Baldassano RN, Milov DE, for PIBDNet—the Pediatric IBD Network for Research and Improvement.  Initial dosage of 6-mercaptopurine in pediatric Crohn’s disease: a study of variation in care.  J Pediatr Gastroenterol 2006;43(supp2):S41

PIBDNet—the Pediatric IBD Network for Research and Improvement

Milov D, Baldassano R, Colletti R, Margolis P, for PIBDNet—the Pediatric IBD Network for Research and Improvement. PIBDNet—the Pediatric IBD Network for Research and Improvement.  J Pediatr Gastroenterol Nutr 2005;41:536

Variation in initial evaluation and treatment of pediatric Crohn disease

Colletti R, Baldassano R, Milov D, Margolis P, for PIBDNet—the Pediatric IBD Network for Research and Improvement. Variation in initial evaluation and treatment of pediatric Crohn disease.  J Pediatr Gastroenterol Nutr 2005;41:537

Variation in initial 6-mercaptopurine dosage in Crohn disease

Baldassano R, Colletti R, Milov D, Margolis P, for PIBDNet—the Pediatric IBD Network for Research and Improvement. Variation in initial 6-mercaptopurine dosage in Crohn disease.  J Pediatr Gastroenterol Nutr 2005;41:537

Built by Veracity Media on NationBuilder